Allscripts Healthcare Solutions (MDRX) 12.05

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allscripts Healthcare Solutions (MDRX) 12.05 $MDRX

Allscripts Healthcare Solutions Shares Down 22.5% Since SmarTrend's Sell Call (MDRX)
Comtex SmarTrend(R) - Fri Mar 20, 10:04AM CDT
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 8 months, Allscripts Healthcare Solutions has returned 22.51% as of today's recent price of $12.00.
MDRX: 12.05 (-0.06)

CERN, MDRX rally as Baird turns bullish; QSII slips on downgrade
Seeking Alpha - at Seeking Alpha - Thu Mar 19, 12:09PM CDT

NUAN: 14.18 (-0.09), QSII: 16.00 (unch), MDRX: 12.05 (-0.06), CERN: 73.73 (-0.09)

Allscripts and NoteSwift Enter Into Collaboration for Greater Efficiency of Electronic Healthcare Records
PR Newswire - Thu Mar 19, 7:30AM CDT
NoteSwift, Inc. and Allscripts (NASDAQ:MDRX) have entered into an agreement for Allscripts to market and resell NoteSwift 2.0 for Allscripts Professional EHR(TM). In response to customer demand, this strategic agreement may help providers reduce the time spent on creating patient documentation by more than half through the use of medical speech recognition.
MDRX: 12.05 (-0.06)

Black Book Market Research Names Allscripts Top Inpatient Electronic Health Record Vendor
GlobeNewswire - Thu Mar 19, 7:01AM CDT
Black Book Rankings(TM) named Allscripts (Nasdaq:MDRX) Sunrise platform as the top overall inpatient electronic health record (EHR) for large hospitals and academic medical centers in 2015. Allscripts Sunrise also achieved this recognition in 2014.
MDRX: 12.05 (-0.06)

US Healthcare IT Market Outlook 2015-2020
M2 - Fri Mar 13, 9:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cxgw8m/us_healthcare_it) has announced the addition of the "US Healthcare IT Market Outlook 2020" report to their offering. The US Healthcare IT market is witnessing an astonishing growth as the country becomes the largest healthcare market across the globe and its rising healthcare cost becomes a foremost concern for the US government today. As a result, with stricter government regulations and increasing adoption of healthcare IT systems in hospitals, the industry is offering immense opportunities for new and existing players taking up the business. In their latest research study US Healthcare IT Market Outlook 2020, the analysts have identified and deciphered the market dynamics in important segments thus clearly highlighting the areas offering promising possibilities for companies to boost their growth. The US healthcare IT market is slated to grow at a CAGR of nearly 9% during 2015-2020. This remarkable growth is to be driven by rapid introductions of new products, growing government support and declining implementation cost of healthcare IT. Moreover, with the emergence of advanced technologies such as cloud computing and big data making a buzz, the US Healthcare IT market is poised to reach new heights. In the present report, the market has been studied on two main grounds - by component and by segment where the component-wise healthcare IT market section covers an in-depth analysis of the healthcare IT hardware, software and services market and the segment-wise healthcare market analysis section includes detailed study of clinical and non-clinical information systems. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Market Trends and Drivers 4. Healthcare IT Market Outlook 2020 5. Potential Growth Areas 6. Regulatory Assessment 7. Competitive Landscape - Allscripts Healthcare Solutions, Inc. - GE Healthcare - McKesson Corporation - Cerner Corporation - Athenahealth Inc - Medical Information Tech Inc. For more information visit http://www.researchandmarkets.com/research/cx...lthcare_it
MCK: 229.94 (+4.19), MDRX: 12.05 (-0.06), CERN: 73.73 (-0.09)

22.8% Return Seen to Date on SmarTrend Allscripts Healthcare Solutions Call (MDRX)
Comtex SmarTrend(R) - Fri Mar 13, 9:29AM CDT
SmarTrend identified a Downtrend for Allscripts Healthcare Solutions (NASDAQ:MDRX) on August 4th, 2014 at $15.49. In approximately 7 months, Allscripts Healthcare Solutions has returned 22.83% as of today's recent price of $11.95.
MDRX: 12.05 (-0.06)

Current Happenings in the Technology Sector: Special Research on Aspen Technology, Advent, Agilysys, Amdocs, and Allscripts
PR Newswire - Thu Mar 12, 6:50AM CDT
Editor Note: For more information about this release, please scroll to bottom.
AZPN: 39.26 (+0.86), AGYS: 9.94 (+0.29), MDRX: 12.05 (-0.06), ADVS: 44.18 (-0.05), DOX: 53.99 (+0.44)

South Nassau Communities Hospital Expands Allscripts Sunrise(TM) With Anesthesiology to Clinicians' iPads
GlobeNewswire - Wed Mar 11, 12:00PM CDT
South Nassau Communities Hospital chose Allscripts (Nasdaq:MDRX) to provide its anesthesia information management system (AIMS). The solution, iPro Anesthesia from iProcedures, integrates with the Allscripts Sunrise(TM) electronic health record (EHR) to ensure a complete and continuous patient record anywhere anesthesia care is provided.
MDRX: 12.05 (-0.06)

Healthcare IT Market in Africa 2015-2019 with GE Healthcare, InterSystems, Philips Healthcare & Siemens Healthcare Dominating
M2 - Tue Mar 10, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qsz3tf/healthcare_it) has announced the addition of the "Healthcare IT Market in Africa 2015-2019" report to their offering. The Healthcare IT market in Africa to grow at a CAGR of 10.04% over the period 2014-2019 The Healthcare IT market is Africa is categorized into three segments: Hardware, Software, and Services. The report, Healthcare IT Market in Africa 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the market landscape and its growth prospects in the coming years. The report also covers the profile of key vendors along with several other prominent vendors operating in this space. Increased adoption of various technologies is one key trend being witnessed in this market. Technologies such as cloud computing, social networking, BI, 3D printing, mobility, and analytics solutions are rapidly being adopted in the Healthcare industry for storage of patient data, diagnostics, and services. According to the report, increased initiatives by governments are a major driver of the market. Currently, various governments in Africa are searching for viable options to form an organized healthcare delivery structure and improve the overall quality of patient care. They are encouraging the installation of HISs in healthcare institutions to create a comprehensive national healthcare system. Further, the report states that increased security concerns are a major challenge in the market. The medical history of patients is shared among the concerned doctors, hospitals, and pharmacies for rapid diagnosis and treatment of disease. Stringent measures and protocols are therefore required to prevent misuse or trading of such confidential information. Key Vendors - GE Healthcare - InterSystems - Philips Healthcare - Siemens Healthcare Other Prominent Vendors - 21st Century Informatics - 3M - Adcock Ingram - Agfa-Gevart NV - Agility Global Health Solutions - Allscripts Healthcare Solutions - Athenahealth - Bytes Technology Group - Carestream Health - Cerner - Cipla Medpro - eClinicalWorks - EIPICO - E-MDS - Epic - Gijima Group - HP Healthcare - Mckesson - Medical Information Tech - Mediware Information System - Novarad - Roche Group - Sekunjalo Healthcare - TIBCO software - Trifour Healthcare - T-Systems Enterprise Services For more information visit http://www.researchandmarkets.com/research/qs...lthcare_it
MDRX: 12.05 (-0.06), CERN: 73.73 (-0.09)

Allscripts and Elsevier Join Forces to Elevate Health Care and Patient Outcomes for U.S. Military Members and Families
GlobeNewswire - Mon Mar 09, 12:00PM CDT
Celebrating a 10-year partnership, Allscripts (Nasdaq:MDRX) and Elsevier Clinical Solutions are raising the level of patient care decision-making support for clinicians by embedding Elsevier's CPM Framework in Allscripts Sunrise electronic health record (EHR). The collaboration strengthens coordination of patient care capabilities in the Allscripts Sunrise EHR, the core of the solution Allscripts and CSC (NYSE:CSC) exclusively proposed to the U.S. Department of Defense (DoD) for the DoD Healthcare Management System Modernization (DHMSM).
CSC: 66.73 (-0.05), MDRX: 12.05 (-0.06)

Quality Systems falls on RBC downgrade; Allscripts ticks lower
Seeking Alpha - at Seeking Alpha - Mon Mar 09, 10:57AM CDT

MDRX: 12.05 (-0.06), QSII: 16.00 (unch)

Allscripts Healthcare Solutions (MDRX) Showing Signs Of A Dead Cat Bounce Today
at The Street - Mon Mar 02, 2:39PM CST
Trade-Ideas LLC identified Allscripts Healthcare Solutions (MDRX) as a "dead cat bounce" (down big yesterday but up big today) candidate
MDRX: 12.05 (-0.06)

Allscripts Healthcare Solutions (MDRX) Upgraded From Sell to Hold
at The Street - Mon Mar 02, 7:34AM CST
Allscripts Healthcare Solutions (MDRX) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C-.
MDRX: 12.05 (-0.06)

NantHealth and Allscripts Join Forces to Develop Precision Solutions at Point of Care in This Era of Genomic Medicine
GlobeNewswire - Mon Mar 02, 7:01AM CST
NantHealth and Allscripts (Nasdaq:MDRX) will collaborate on the development and delivery of cutting-edge, precision medicine solutions directly to the point of care. The companies will introduce an integrated, evidence-based, personalized approach to healthcare solutions that includes actionable clinical data, enabling physicians to make informed decisions from complex genomic and proteomic analysis.
MDRX: 12.05 (-0.06)

Allscripts Healthcare Solutions (MDRX) Stock Falls on Revenue Miss
at The Street - Fri Feb 27, 2:11PM CST
Allscripts Healthcare Solutions (MDRX) is falling Friday after missing analysts' estimates for revenue in the fourth quarter and issuing a mixed guidance.
MDRX: 12.05 (-0.06)

Most active Nasdaq-traded stocks
AP - Fri Feb 27, 12:26PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
HERO: 0.49 (unch), CYCC: 0.98 (+0.02), FB: 83.80 (+1.05), CYTX: 1.19 (-0.03), MDRX: 12.05 (-0.06), SPLK: 62.12 (-1.61), ARCP: 10.09 (+0.23), MSFT: 42.88 (+0.60), AAPL: 125.90 (-1.60), CSCO: 28.44 (+0.18)

Allscripts -8.2% on revenue miss, bookings drop, soft sales guidance
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 10:57AM CST

MDRX: 12.05 (-0.06)

Water-Logged And Getting Wetter: Allscripts Healthcare Solutions (MDRX)
at The Street - Fri Feb 27, 9:57AM CST
Trade-Ideas LLC identified Allscripts Healthcare Solutions (MDRX) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
MDRX: 12.05 (-0.06)

Allscripts (MDRX) Tops Q4 Earnings by a Penny, Revenues Lag - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 8:48AM CST
Allscripts Healthcare Solutions Inc. (MDRX) reported adjusted EPS of 8 cents in the fourth quarter of 2014, which beat the Zacks Consensus Estimate by a penny
ABAX: 65.61 (+1.33), MDRX: 12.05 (-0.06), LMNX: 15.98 (-0.08), AFFX: 12.87 (-0.07)

Allscripts Healthcare Solutions' (MDRX) CEO Paul Black on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 26, 8:30PM CST

MDRX: 12.05 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading